← 홈

전체 프로그램

ADC 1032 · Antibody 4684 · CGT 2713 · 다음 갱신 D-14 · 마지막 7월 31일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,531개
CGTBiologicstaleFondazione Policlinico Universi…Phase 2

Haplo SCT with NK cells (Haplo SCT with NK cells)

Acute Myeloid Leukemia; Myelodysplasia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
AntibodystaleShuhong YiPhase 2

atezolizumab (Tecentriq, Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab)

Recurrent Liver Cancer After Liver Transplantation · Recurrent Liver Cancer After Liver Trans

#RecurrentLiverCancerAfterLiverTr#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

trastuzuamb (Herceptin, Herceptin (trastuzuamb))

HER2 Positive Early or Locally Advanced Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
효능 ORR 91.2%임상시험 1상태 ACTIVE
AntibodystaleRochePreclinical

trastuzumab (Herceptin, Herceptin (trastuzumab))

Breast Neoplasms · Breast Neoplasms

#BreastNeoplasms#Antibody#Preclinical#항체#면역항체+2
효능 ORR 91.2%임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 1

trastuzumab (Herceptin, Herceptin EU)

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

trastuzumab (Herceptin, Herceptin Hylecta®)

Healthy Male Participants · Healthy Male Participants

#HealthyMaleParticipants#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 1

trastuzumab (Herceptin, Herceptin US)

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleNingbo Cancer HospitalPhase 2

HerinCAR-PD1 cells (HerinCAR-PD1 cells)

PD-1 Antibody; CAR-T Cells · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
ADCBiologicstaleOu Bai, MDPhase 2

Hi-miniCHOP +orelabrutinib (Hi-miniCHOP +orelabrutinib)

DLBCL - Diffuse Large B Cell Lymphoma · DLBCL - Diffuse Large B Cell Lymphoma

#DLBCL-DiffuseLargeBCellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleOu Bai, MDPhase 2

HiMTO (HiMTO)

DLBCL - Diffuse Large B Cell Lymphoma · DLBCL - Diffuse Large B Cell Lymphoma

#DLBCL-DiffuseLargeBCellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 1

High dose cytarabine for consolidation (High dose cytarabine for consolidation)

Acute Myeloid Leukemia; Acute Myelogenous Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
CGTBiologicstaleGuangzhou Women and Children's …Phase 3

High-dose CAR-T cells group (High-dose CAR-T cells group)

Lupus Nephritis · Lupus Nephritis

#LupusNephritis#CGT#Phase3#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

High-dose Epirubicin Combined with CVP ± Rituximab (High-dose Epirubicin Combined with CVP ± Rituximab)

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleWeill Medical College of Cornel…Phase 3

Higher Dose of Rituximab (Higher Dose of Rituximab)

Immune Thrombocytopenic Purpura · Immune Thrombocytopenic Purpura

#ImmuneThrombocytopenicPurpura#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleImmunoGen, Inc.Phase 1

HuC242-DM4 (HuC242-DM4)

Non-colorectal Cancer; Pancreatic Cancer · Non-colorectal Cancer

#Non-colorectalCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 3

adalimumab (Humira, Human anti-TNF monoclonal antibody/adalimumab)

Psoriatic Arthritis · Psoriatic Arthritis

#PsoriaticArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 1

adalimumab-EU (Humira, Humira (adalimumab-EU))

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 1

adalimumab-US (Humira, Humira (adalimumab-US))

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePhase 1

adalimumab (Humira, Humira®, Humira® (adalimumab) AC Pen [Reference Product])

Pharmacokinetics; Safety Issues · Pharmacokinetics

#Pharmacokinetics#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleHunan Province Tumor HospitalPhase 2

IBI-323 combined with bevacizumab plus Platinum (IBI-323 combined with bevacizumab plus Platinum)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

121 / 177 페이지

← 이전다음 →